PROTAC has opened up a new path to drug the ‘undruggable ‘ protein candidates and has taken drug discovery for small molecules to an extraordinary level. The challenge is to find ways to expedite the drug discovery process by overcoming the bottlenecks with the workflow.
Dr. Emelyne Diers - University of Dundee
Cyrille S. Kounde BSc - Imperial College London
Dr. Induka Abeysena - SP Genevac
On October 7th, 2020 at 3pm GMT, Biopharma Group & SP Genevac, will host a 1 hour live webinar that aims to provide an introduction to PROTAC & how a better understanding of the ternary complex between the PROTAC, the POI & an E3 ubiquitin ligase can lead to rationally designed degraders. Additionally, we will also discuss activation & delivery control strategies in a cellular environment & key points for eliminating evaporation bottlenecks during the synthesis & purification stages of PROTAC research.